BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 30305116)

  • 1. Role of platelets and platelet receptors in cancer metastasis.
    Schlesinger M
    J Hematol Oncol; 2018 Oct; 11(1):125. PubMed ID: 30305116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development.
    Lee RH; Bergmeier W
    J Thromb Haemost; 2016 Apr; 14(4):645-54. PubMed ID: 26749528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
    Mammadova-Bach E; Gil-Pulido J; Sarukhanyan E; Burkard P; Shityakov S; Schonhart C; Stegner D; Remer K; Nurden P; Nurden AT; Dandekar T; Nehez L; Dank M; Braun A; Mezzano D; Abrams SI; Nieswandt B
    Blood; 2020 Apr; 135(14):1146-1160. PubMed ID: 32040544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLEC-2 expression is maintained on activated platelets and on platelet microparticles.
    Gitz E; Pollitt AY; Gitz-Francois JJ; Alshehri O; Mori J; Montague S; Nash GB; Douglas MR; Gardiner EE; Andrews RK; Buckley CD; Harrison P; Watson SP
    Blood; 2014 Oct; 124(14):2262-70. PubMed ID: 25150298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the PI3-kinase/Akt pathway on ITAM and hemITAM receptors: haemostasis, platelet activation and antithrombotic therapy.
    Moroi AJ; Watson SP
    Biochem Pharmacol; 2015 Apr; 94(3):186-94. PubMed ID: 25698506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
    Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glycoprotein VI to disrupt platelet-mediated tumor cell extravasation.
    Tesfamariam B; Wood SC
    Pharmacol Res; 2022 Aug; 182():106301. PubMed ID: 35710063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of platelets in tumor cell metastasis.
    Tesfamariam B
    Pharmacol Ther; 2016 Jan; 157():112-9. PubMed ID: 26615781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis.
    Shu L; Lin S; Zhou S; Yuan T
    Platelets; 2024 Dec; 35(1):2315037. PubMed ID: 38372252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis.
    Shi Q; Ji T; Tang X; Guo W
    Cell Oncol (Dordr); 2023 Jun; 46(3):521-532. PubMed ID: 36652166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
    Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
    Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet ITAM signaling.
    Bergmeier W; Stefanini L
    Curr Opin Hematol; 2013 Sep; 20(5):445-50. PubMed ID: 23921514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of platelet in cancer progression and metastasis.
    Zhou L; Zhang Z; Tian Y; Li Z; Liu Z; Zhu S
    Eur J Med Res; 2023 Sep; 28(1):385. PubMed ID: 37770941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets in cancer metastasis: To help the "villain" to do evil.
    Li N
    Int J Cancer; 2016 May; 138(9):2078-87. PubMed ID: 26356352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet adherence to cancer cells promotes escape from innate immune surveillance in cancer metastasis.
    Okazaki M; Yamaguchi T; Tajima H; Fushida S; Ohta T
    Int J Oncol; 2020 Oct; 57(4):980-988. PubMed ID: 32945350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type lectin like receptor 2 (CLEC-2) signals independently of lipid raft microdomains in platelets.
    Manne BK; Badolia R; Dangelmaier CA; Kunapuli SP
    Biochem Pharmacol; 2015 Jan; 93(2):163-70. PubMed ID: 25462818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet "first responders" in wound response, cancer, and metastasis.
    Menter DG; Kopetz S; Hawk E; Sood AK; Loree JM; Gresele P; Honn KV
    Cancer Metastasis Rev; 2017 Jun; 36(2):199-213. PubMed ID: 28730545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet CLEC-2 and podoplanin in cancer metastasis.
    Lowe KL; Navarro-Nunez L; Watson SP
    Thromb Res; 2012 Apr; 129 Suppl 1():S30-7. PubMed ID: 22682130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity.
    Boulaftali Y; Hess PR; Kahn ML; Bergmeier W
    Circ Res; 2014 Mar; 114(7):1174-84. PubMed ID: 24677237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Tumor Cell-Induced Platelet Aggregation and Granule Secretion.
    Schwarz S; Schlesinger M; Bendas G
    Methods Mol Biol; 2021; 2294():181-195. PubMed ID: 33742402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.